Ultrasound-guided Interscalene Block Versus Infraspinatus-Teres Minor Plane Block in Shoulder Arthroscopy

NCT ID: NCT07016386

Last Updated: 2025-07-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

46 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-06-15

Study Completion Date

2026-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to compare the efficacy and safety of ultrasound-guided Interscalene block (ISB) versus Infraspinatus-Teres minor (ITM) interfacial plane block in shoulder arthroscopic surgery.

A prospective, randomized clinical trial will be conducted with 46 patients. Approval was obtained from the Medical Ethics Committee (2022/0126), and written informed consent will be collected from all participants. Patients aged 20-70, ASA I-II, scheduled for arthroscopic shoulder surgery will be divided before the induction of general anesthesia (GA) into two groups:

Group A: will receive the ultrasound guided ISB technique with a 15ml solution of 7.5ml lidocaine 2% and 7.5ml bupivacaine 0.5% be injected between the anterior and middle scalene muscles.

Group B: will receive the ultrasound guided ITM block with the same anesthetic solution be injected between the infraspinatus and teres minor muscles.

Researchers will examine the following outcomes;

1. Primary outcome measure: Efficacy of analgesia by Pain score; will be measured by Numerical Rating Scale (NRS) score (0=no pain,1-3=mild,4-6=moderate,7-9=sever,10=most sever) at postoperative 12 hour.
2. Secondary outcome measures:

1. Duration of analgesia, starting from recovery from general anesthesia (GA) to 1st time giving the patient rescue analgesia ( measured by NRS pain score at 0, 6 ,12, 18 and 24 postoperative hours)
2. Risk of complications from techniques
3. Patient satisfaction after surgery.
4. Rescue analgesic consumption
5. Hemodynamics monitoring; measurements of heart rate and mean arterial blood pressure before induction of anesthesia and every 15 minutes during surgery till end of surgery

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

I. Study design:

Randomized comparative study.

II. Study setting and location:

The study will be conducted at the operative room of Souad Kafafi University Hospital (SKUH), Misr University of science and Technology (MUST).

III. Study population:

Patients aged from 20 to 60 years old scheduled for shoulder surgery will be randomized in a 1:1 ratio after induction of general anesthesia (GA) to either: Group A: Received the ultrasound guided ISB technique with a 15ml solution of 7.5ml lidocaine 2% and 7.5ml bupivacaine 0.5% injected between the anterior and middle scalene muscles.

Group B: Received the ultrasound guided ITM block with the same anesthetic solution injected between the infraspinatus and teres minor muscles.

IV. Study procedures:

1. Randomization Patients will be randomly allocated by a computer-generated table into one of the study groups; the randomization sequence will be concealed in sealed opaque envelopes.
2. Study protocol

* All Patients will have a pre-operative assessment visit, which will include; history taking, complete physical examination and review of all the results of the routine investigations (CBC, Coagulation profile, renal functions, liver functions).
* On Arrival to the preparation room, they will receive the following premedication via intravenous (IV) route: Midazolam 0.03 mg/kg, Ondansetron 4 mg and Omeprazole 40 mg iv infusion.
* Upon Arrival to the operating room, standard monitoring will be applied which include: Pulse Oximeter, Noninvasive Blood Pressure and Six-lead electrocardiogram (ECG).
* General anesthesia will be induced using: Propofol 1-2mg/kg, Fentanyl1-2 μg/kg, Morphine 0.1mg/kg and Atracurium 0.5 mg/kg.
* After endotracheal intubation, side way capnography will be applied to measure end tidal CO2 pressure in the expired air.
* General anesthesia will be maintained using Sevoflurane 1-2 MAC (Mean Alveolar Concentrations) in O2/ Air 50% / 50%, Paracetamol 1gm iv infusion, ketorolac 30 mg iv and incremental doses of Atracurium 0.1mg/kg/30 minutes.

The patients will be randomly allocated into two groups:

Group A:

Ultrasound-guided Interscalene block (ISB) technique.

Group B:

Ultrasound-guided Infraspinatus-teres minor (ITM) interfacial plane block technique

V. Study outcomes:

1. Primary outcome measure:

• Efficacy of analgesia by Pain score; will be measured by Numerical Rating Scale (NRS) score (0-10; 0=no pain,1-3=mild,4-6=moderate,7-9=sever,10=most sever) at postoperative12 hours.
2. Secondary outcome measures:

1. Duration of analgesia, starting from recovery from general anesthesia (GA) to 1st time giving the patient rescue analgesia ( measured by NRS pain score at 0, 6 ,12, 18 and 24 postoperative hours).
2. Risk of complications from techniques.
3. Patient satisfaction after surgery
4. Total intraoperative analgesia dose (fentanyl consumption) and total postoperative analgesia dose (morphine consumption).
5. Hemodynamics monitoring; measurements of heart rate and mean arterial blood pressure before induction of anesthesia and every 15 minutes during surgery till end of surgery

VII. Statistical analysis:

1. Sample size:

Sample size calculation was based on pain score after Interscalene block (ISB) in shoulder surgery versus other methods retrieved from previous research (Singelyn et al., 2004) (15). Using G power program version 3.1.9.4 to calculate sample size based on effect size of 0.897 (35 ± 25) versus (13±24), using 2-tailed test, α error =0.05 and power = 80.0%, the total calculated sample size will be 21 in each group at least and by adding 10% to compensate for possible drop out then total sample size per group is 23 cases at least.
2. Statistical analysis:

Data will be analyzed using SPSS (statistical package for social sciences) version 22. Quantitative data will be tested for normality by Kolmogrov-Smironv test then described as mean and standard deviation for normally distributed data, and median and range for non-normally distributed, Qualitative data will be presented as number and percent. The appropriate statistical test will be applied according to data type with the following suggested tests: Student t test and Mann Whitney U test for continuous variables, Chi-Square test for categorical variable.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain Pain Management Pain Management in Postoperative Care

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Outcome Assessors
The participants, care providers and outcome assessor will be blind regarding the procedure

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group A : Ultrasound guided Interscalene block (ISB) technique

Interscalene block (ISB) technique, patients will be place in the supine position and the patient's head facing away from the side to be blocked. The Ultrasound probe will be applied in sterile fashion on the supraclavicular fossa to find the brachial plexus division lateral to the subclavian artery. Then, the probe will be traced cephalad to the C5-C6 root and interscalene muscles at the level of the cricoid cartilage

Group Type ACTIVE_COMPARATOR

Group A: will receive an ultrasound-guided interscalene block (ISB)

Intervention Type PROCEDURE

Group A: will receive an ultrasound-guided interscalene block (ISB) using a 15ml mixture of lidocaine (7.5ml 2%) and bupivacaine (7.5ml 0.5%).

Group B: Ultrasound guided Infraspinatus-teres minor (ITM) interfacial plane block technique

Infraspinatus-teres minor (ITM) interfacial plane block technique, Patients will be placed in the lateral position, and a pillow will be wedged under the anterior shoulder and upper arm. The Ultrasound probe will be applied in sterile fashion and put angled obliquely, to be perpendicular to the direction of muscles to obtain the transverse scan of muscles for the ITM block. After palpation of the posterolateral corner of the acromion, the muscle-tendon units of infraspinatus (IS) and teres minor (Tm) on the humeral head will be identified below the corner. At this time, the probe will be moved slightly caudad to identify the borders of Tm. Once the IS and Tm on the humeral head area identified, by moving the probe medio caudally, the interfascial structure of the IS and Tm could be traced on the posterior surface area of the neck of the scapula.

Group Type EXPERIMENTAL

Group B:will receive an ultrasound-guided infraspinatus-teres minor (ITM) interfacial plane block

Intervention Type PROCEDURE

Group B:will receive an ultrasound-guided infraspinatus-teres minor (ITM) interfacial plane block using a 15ml mixture of lidocaine (7.5ml 2%) and bupivacaine (7.5ml 0.5%).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Group A: will receive an ultrasound-guided interscalene block (ISB)

Group A: will receive an ultrasound-guided interscalene block (ISB) using a 15ml mixture of lidocaine (7.5ml 2%) and bupivacaine (7.5ml 0.5%).

Intervention Type PROCEDURE

Group B:will receive an ultrasound-guided infraspinatus-teres minor (ITM) interfacial plane block

Group B:will receive an ultrasound-guided infraspinatus-teres minor (ITM) interfacial plane block using a 15ml mixture of lidocaine (7.5ml 2%) and bupivacaine (7.5ml 0.5%).

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients aged 20 to 60,
* ASA classification I or II,
* scheduled for arthroscopic shoulder surgery,
* will be randomized 1:1 into two groups before the induction of general anesthesia (GA)

Exclusion Criteria

* Patients who refuse participation.
* Have allergies to local anesthetics.
* Phrenic nerve dysfunction.
* Chronic opioid use.
* ASA III or higher classification.
* Coagulopathy.
* Severe chronic obstructive pulmonary disease.
* Local infection at the injection site
Minimum Eligible Age

20 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Misr University for Science and Technology

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Emad Lotfy Mohammed Ahmed

Lecturer of Anesthesia, SICU & Pain management

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mohammed Hany Kamal, Prof. of anesthesia and pain

Role: STUDY_CHAIR

Misr University for Science and Technolog

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Souad Kafafi University Hospital (SKUH), Faculty of medicine, Misr University for Science and Technology (MUST)

Giza, Giza Governorate, Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

References

Explore related publications, articles, or registry entries linked to this study.

Hewson DW, Oldman M, Bedforth NM. Regional anaesthesia for shoulder surgery. BJA Educ. 2019 Apr;19(4):98-104. doi: 10.1016/j.bjae.2018.12.004. Epub 2019 Feb 6. No abstract available.

Reference Type BACKGROUND
PMID: 33456877 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2022/0126

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.